** Shares of biopharma firm Cara Therapeutics CARA.O rise 14.5% to $5.61
** Cara says that its board has approved a 1-for-3 reverse stock split, effective April 15
** Cara entered into a merger agreement with privately held Tvardi Therapeutics in December
** The stock split will be under the new name Tvardi Therapeutics Inc and symbol "TVRD" after the anticipated closing of the merger
** After the closing of the merger, the combined company's total outstanding shares are expected to be about 9.4 million
** As of last close, CARA had fallen 14.2% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。